Repligen Corp logo

Repligen Corp

$ 191.06 +2.29 (+1.21%) 04:00 PM EST
P/E:
68.22
P/B:
5.80
Market Cap:
$ 10.49B
Enterprise V:
$ 10.30B
Volume:
469.46K
Avg Vol (2M):
534.70K
Also Trade In:
Volume:
469.46K
Market Cap $:
10.49B
PE Ratio:
68.22
Avg Vol (2-Month):
534.70K
Enterprise Value $:
10.30B
PB Ratio:
5.80
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Name Current Vs Industry Vs History
Cash-To-Debt 1.43
Equity-to-Asset 0.74
Debt-to-Equity 0.23
Debt-to-EBITDA 1.69
Interest Coverage 28.8
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.87
Distress
Grey
Safe
Beneish M-Score -2.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.57
9-Day RSI 34.21
14-Day RSI 36.89
6-1 Month Momentum % 26.5
12-1 Month Momentum % -20.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.3
Quick Ratio 1.74
Cash Ratio 1.41
Days Inventory 207.94
Days Sales Outstanding 54.89
Days Payable 37.59

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8

Financials (Next Earnings Date:2022-10-26 Est.)

RGEN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RGEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 778.77
EPS (TTM) ($) 2.77
Beta 1.01
Volatility % 46.46
14-Day RSI 36.89
14-Day ATR ($) 10.239842
20-Day SMA ($) 212.0995
12-1 Month Momentum % -20.46
52-Week Range ($) 137.21 - 306.98
Shares Outstanding (Mil) 55.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Repligen Corp Filings

Document Form Filing Date
No Filing Data

Repligen Corp Analysis

Share your research

Headlines

See More
No news.